Construction and Characterization of Adenovirus Vectors Encoding Aspartate- β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma.

In conclusion, the gateway recombinant cloning technology is a powerful method of constructing adenovirus vector, and the product Ad-AAH-IRES2-EGFP may present as a potential candidate for DC-based immunotherapy of HCC. PMID: 30116759 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30116759?dopt=Abstract

Source: Journal of Immunology Research - August 18, 2018 Category: Allergy & Immunology Tags: J Immunol Res Source Type: research